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Abstract
Evidence-based practice depends in part on knowledge derived from relevant research.
For any given topic, there are likely to be many, potentially relevant studies; a careful appraisal
and synthesis of the results of these studies is needed to understand the state of the empirical
evidence. Meta-analysis is widely used to combine results of quantitative studies; yet this method
is unfamiliar to many people and, as a result, meta-analyses are often uncritically accepted. In
this article, we argue that meta-analysis is only one component of a good research synthesis. We
critique a recent metaanalysis on the effectiveness of long-term psychodynamic psychotherapy,
showing that this metaanalysis failed to meet current standards for the conduct and reporting of
systematic research reviews and meta-analyses. We demonstrate the use of AMSTAR, a
straightforward tool for assessing the quality of systematic reviews and meta-analyses.
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Evidence-based practice depends in no small measure on the identification, critical
appraisal, and accurate synthesis of relevant research results. Methods of research
synthesis have come a long way since Glass (1976) coined the term “meta-analysis” to
describe the statistical combination of data from multiple studies. Meta-analysis is now
widely used in the social, behavioral, and health sciences; yet, many people are unfamiliar
with this approach and, as a result, meta-analyses are often uncritically accepted. In this
article, we critique a recent meta-analysis on the effectiveness of long-term psychodynamic
psychotherapy (LTPP) by Leichsenring and Rabung (2008). This meta-analysis appeared in
JAMA, where Glass himself pronounced that it “was carefully performed” (2008, p. 1589)
and others disagreed (Beck & Bhar, 2009; Kriston, Holzel, & Harter, 2009; Glass, 2008;
Roepke, 2009; Thombs, Bassel, & Jewett, 2009). We argue that meta-analysis is only one
component of a systematic approach to reviewing research, and the LTPP meta-analysis
failed to meet current standards for the conduct and reporting of systematic reviews and
meta-analyses.
The LTPP meta-analysis is controversial in terms of its content as well as its methods.
For many years now, the treatment and research worlds have witnessed the ascendancy of
short-term cognitive and behavioral therapies. At face value, the article by Leichsenring
and Rabung calls into question the move toward short-term treatment of a range of mental
health issues.
As evidence-based practice has developed over the years, so too have the tools
needed to quickly and competently evaluate the presentation of findings from different
types of studies, including random controlled trials, studies of diagnostic accuracy,
observational studies, systematic reviews, and meta-analyses (see http://www.equator-
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network.org). There are now also user-friendly tools to evaluate the quality of completed
studies. We demonstrate the application of just such a tool (AMSTAR; Shea et al., 2007) for
assessing the quality of systematic research reviews.
Background
Systematic reviews and meta-analysis can provide comprehensive, accurate, and
useful summaries of empirical research on a wide range of topics that are important to
clinicians and consumers. Careful research syntheses can capture what is known about the
incidence and prevalence of various conditions; the associations between behavioral,
psychological, social, and health conditions; the accuracy of various diagnostic tests; and
the effectiveness of treatments.
However, as a “stand alone” method, meta-analysis is entirely insufficient for research
reviews, just as statistical analysis is insufficient for survey research. Survey researchers
are concerned with sampling, measurement, and data collection, in addition to proper
analysis of data. Similarly, the validity of a meta-analysis hinges on a series of decisions that
are made during the review process: decisions about the types of studies that will be
included, strategies to locate relevant studies, critical appraisal of those studies, and steps
to minimize bias and error at each step in the review process.
There is a large body of empirical research that places meta-analysis in its proper
context: as a potentially useful set of statistical techniques for research synthesis in the
context of a systematic review (Littell, Corcoran, & Pillai, 2008). Systematic reviews, such
those produced by the Campbell Collaboration and the Cochrane Collaboration, use
transparent and replicable methods to minimize bias and error. Unfortunately, these
strategies are absent in many published meta-analyses in psychology, social work,
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medicine, and other fields.
The meta-analysis on effectiveness of LTPP by Leichsenring & Rabung (2008) is a
case in point: it is one of many recent, published meta-analyses that ignored much of the
available evidence about the conduct and reporting of valid research syntheses.
Meta-analysis of the effectiveness of LTPP
Leichsenring and Rabung (L&R; 2008) reported results of a meta-analysis of 11
randomized controlled trials and 12 observational studies of individual psychodynamic
psychotherapy. Study participants had chronic, complex, and multiple mental disorders
(e.g., anxiety, depression, and personality disorders). In some studies, LTPP was compared
with shorter forms of therapy (e.g., inpatient treatment, partial hospitalization, cognitive
therapy, dialectic behavioral therapy, or nutritional counseling); in other studies LTPP was
evaluated by comparing post-treatment results to baseline data. Measures of effectiveness
focused on change over time within the LTPP groups. Meta-analysis was used to combine
these results across studies.
L&R claimed that their meta-analysis was conducted in a manner “consistent with
recent guidelines for the reporting of meta-analyses” (2008, p. 1552). This is only partially
true. They cited two sets of reporting guidelines: the QUOROM statement (Moher et al.,
1999; which was subsequently replaced by the PRISMA statement; Moher et al., 2009) and
the MOOSE statement (Stroop et al., 2000). We compared their article with the reporting
standards they cited and found many gaps in the substance and clarity of their report. We
used the Assessment of Multiple SysTemAtic Reviews (AMSTAR) tool (Shea et al., 2007) to
assess the methodological quality of the L&R meta-analysis. AMSTAR ratings are shown in
Table 1 and discussed below.
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1. An a priori design should be provided
The Cochrane and Campbell Collaborations require a detailed protocol for a
systematic review that spells out the central questions, objectives, criteria, search
strategies, and methods for the review. This protocol is peer-reviewed and is publicly
available prior to the commencement of the review. Detailed protocols increase
transparency and reduce discretion in the conduct of systematic reviews and metaanalyses. L&R did not provide an a priori design for their meta-analysis (i.e., no protocol
was made public in advance of the completed review).
The research question should be established before the conduct of the review. The
central question in the L&R meta-analysis remains unclear. To understand the effects of
LTPP we must make explicit comparisons to other treatments or conditions. Are we
interested in the absolute effects of LTPP (compared with no treatment) or relative effects
(compared with other treatments)? L&R included some studies that compared LTPP to
shorter therapies, alternative treatments, or treatment as usual; but they also included
studies that had no comparison or control groups whatsoever. For the latter group of
studies, only within-group comparisons (pre and post LTPP) are available. These studies
address a fundamentally different question: that is, whether clients who received LTPP
demonstrated changes over time. Observed changes could be due to treatment or to many
other factors. Absent comparisons to parallel cohorts (differently treated groups assessed
in the same timeframe), within-group changes are poor indicators of treatment
“effectiveness.” Given that the studies included in the L&R meta-analysis addressed
different questions, the central question of the meta-analysis is unclear.
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Inclusion criteria should be established before the conduct of the review. Criteria for
inclusion in the L&R meta-analysis were not entirely clear, and some criteria seem to
evolve during the review with post-hoc exclusions of some studies (e.g., those that
compared LTPP to inpatient treatment, and studies that included participants who did not
have Axis I or II diagnoses). There was no detailed explanation of reasons for study
exclusion (also a QUOROM requirement).
2. Study selection and data extraction should be conducted by at least two independent
reviewers.
It is unclear how study selection decisions were made in the LTPP meta-analysis.
L&R indicated that they used duplicate data extraction (presumably after studies were
selected) and a consensus procedure to resolve disagreements for at least some items.
However, they also indicated that they used mean study quality ratings instead of a
consensus procedure.
3. A comprehensive literature search should be performed.
Three databases were searched, but the authors did not present a clear search
strategy. It is not clear how manual searches and contacts with experts were conducted.
The search strategy is neither transparent nor replicable (e.g., it is unclear whether
electronic searches were limited to keywords associated with articles or covered words
that appeared anywhere in the text).
4. Publication status should not be used as an inclusion criterion.
Meta-analyses that are limited to published studies tend to over-estimate treatment
effects (Hopewell et al., 2007), and it is not clear whether L&R did enough to prevent this.
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L&R mentioned publication dates in their inclusion criteria, but also indicated that they
considered one unpublished study. Their meta-analysis was limited to published studies.
5. A list of included and excluded studies should be provided.
L&R did not list excluded studies, nor did they discuss specific reasons for study
exclusion (a stipulation of the QUOROM statement).
6. Characteristics of included studies should be described.
L&R provided partial information in the studies included in their review. They did
not provide information on participants’ demographic characteristics or attrition in the
primary studies. L&R did not follow QUOROM guidelines which instruct reviewers to
“present simple summary results (for each treatment group in each trial, for each primary
outcome); present data needed to calculate effect sizes and confidence intervals in
intention-to-treat analyses (e.g., 2x2 tables of counts, means and SDs, proportions)” (Moher
et al., 1999, p. 1897).
7. Scientific quality of included studies should be assessed and documented
L&R used a simple, linear scale to measure overall study quality. However, overall
quality scores conflate distinct methodological issues, which may have disparate effects on
the reliability and validity of results (Higgins & Green, 2008; Wells & Littell, 2009). Hence,
the “use of summary scores from quality scales is problematic [and] it is preferable to
examine the influence of key components of methodological quality individually” (Jüni et
al., 2001, p. 42).
L&R state that they only included studies with “reliable” outcome measures, but
they do not indicate what types of reliability were considered (e.g., inter-rater, test-retest,
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internal consistency?) and what standards were used to determine whether measures
were reliable.
8. Scientific quality of included studies should be used appropriately in formulating
conclusions.
L&R displayed considerable confusion about research designs and the types of
inferences that can be drawn from them. First, they contrast randomized controlled trials
(RCTs) with “effectiveness studies,” yet many RCTs (field trials) are effectiveness studies.
Second, they use the term “overall effectiveness” to refer to changes within groups over
time (differences between pre-tests and post-tests); however, as indicated above, withingroup differences are measures of change over time, not measures of treatment
effectiveness. Studies of treatment effects must control threats to internal validity (e.g.,
selection bias, maturation, testing effects, other events; see Shadish, Cook & Campbell,
2002). Within-group analyses do not account for the fact that any observed changes could
be due to many factors outside of treatment.
For reasons that are entirely unclear, in some analyses L&R eliminated the allimportant between-group comparisons in RCTs and focused only on changes within the
LTPP group in the RCTs. In essence, they converted the RCTs into observational studies,
stripping the RCTs of their ability to support causal inferences about the effects of LTPP!
L&R claim that there were no significant differences in the results of RCTs versus
observational studies, but this statement is meaningless because the RCTs were essentially
converted to observational studies (stripped of their control groups) in this analysis.
L&R stated that they used data on all study participants (intent-to-treat analyses) if
these data were available. However, it appears that they combined intent-to-treat samples
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in some studies with data from program completers in other studies. The latter are
vulnerable to attrition biases, because program dropouts are generally less satisfied with
the intervention and have less favorable outcomes than program completers. Further, the
post-treatment and follow-up assessments for LTPP groups occurred considerably later
than similar assessments for comparison groups in some studies; this may have
exacerbated problems with differential attrition. That is, it is much easier for someone to
complete a 12-week span of therapy (e.g., CBT) than a much longer course of treatment.
Thus, if offered the chance, many completers of short-term therapy might not have finished
long-term psychotherapy. Since people who complete long-term therapy probably differ
from people who complete short-term therapy (in terms of motivation and other
unmeasured factors), differential attrition could explain observed differences between
LTPP completers and other groups. L&R provide no discussion of attrition bias, outcome
reporting bias, or missing data, although this is required in the QUOROM statement which
they cited.
9. Appropriate methods should be used to combine the findings of studies.
L&R use unconventional effect size metrics that are not fully explained (hence, the
analysis is neither transparent nor replicable). Bhar and colleagues (2010) show that the
approach taken by L&R produces “grossly inaccurate” and inflated estimates of effects. L&R
followed 20 year-old recommendations on the statistical synthesis of data from multiple
studies. For RCTs, they should have used standardized mean differences with adjustments
for small sample bias (Hedges’ g) (see Lipsey & Wilson, 2001; Higgins & Green, 2008).
L&R did conduct homogeneity tests and used random-effects models, as
appropriate.
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In some analyses, L&R made the mistake of combining measures of conceptually
distinct outcomes. Because treatments can have positive effects on some outcomes and null
or negative effects on others, the combination of conceptually distinct outcomes produces
meaningless overall estimates of effects.
To avoid “fishing” for significant effects, subgroup analyses should be limited to a
few a priori contrasts (Higgins & Green, 2008). L&R conducted many subgroup analyses,
unspecified beforehand, thus inflating the risk of a type I error.
10. The likelihood of publication bias should be assessed.
L&R used outdated and inadequate methods to assess the likelihood of publication
bias. The file drawer number (or failsafe N) is misleading and should never be used
(Becker, 2005). L&R also used a rank correlation test published in 1994, although many
newer and better methods were available (Rothman, Sutton, & Bornstein, 2005).
11. Conflicts of interest and sources of support should be clearly acknowledged.
As noted in JAMA, L&R provided no financial disclosures. Leichsenring is the first
author on one of the studies in this review and several previously published meta-analysis
of psychodynamic psychotherapy.
Summary and conclusions
Credible research syntheses use transparent, replicable methods and attempt to
minimize well-known sources and types of bias and error at each step in the review
process. Guidelines for the conduct and reporting of systematic reviews and meta-analyses
are well developed (see Higgins & Green, 2008; Moher et al., 2009). These guidelines are
based on a large body of methodological research on the conduct of primary studies and
research syntheses. Unfortunately, many published meta-analyses and other types of
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research reviews do not take this body of knowledge into account and do not follow
established guidelines for the conduct and reporting of research reviews.
The AMSTAR tool provides a simple way to assess whether central issues were
adequately addressed in a research review. The meta-analysis by L&R fell short on all 11
items on the AMSTAR instrument. This suggests that the L&R meta-analysis of LTPP is
neither transparent nor replicable, and it lacks adequate controls for bias and error. As
such, the meta-analysis by L&R is not a credible synthesis of research on the effectiveness
of LTPP; thus, it does not provide convincing evidence for or against the use of LTPP or
other treatments.
Chalmers and colleagues (1993) noted that the failure to use scientific methods in
locating, appraising, and synthesizing research can have serious consequences, because
service providers rely more on research reviews than primary studies to learn about
treatment effects. “Thus, failure by reviewers to apply scientific principles to this secondary
research can have adverse consequences for patients” and can lead to wasted service
resources (Chalmers et al., 1993, p. 412).
The information age will continue to push the creation and availability of new
knowledge, and credible syntheses of this knowledge will become increasingly important.
As a method of research synthesis, meta-analysis is appealing in many respects. Metaanalysis offers a powerful set of statistical tools for combining and analyzing results across
studies. Compared with narrative reviews of research, meta-analysis provides more
accurate summaries of quantitative studies (Bushman & Wells, 2001). However, like any
statistical technique, meta-analysis can be misused and its results can be misleading. Just
as in survey research, statistical analysis may be necessary but insufficient for valid results.
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The validity of a meta-analysis depends largely on whether it is conducted in the context of
a comprehensive and rigorous systematic review. AMSTAR and other independent and
easy-to-use tools can be useful for practitioners and policy-makers in their efforts to
evaluate the quality of seemingly complex studies and research reviews.
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Table 1: AMSTAR ratings for Leischsenring and Rabung (2008)
AMSTAR item (Shea et al., 2007)

Rating

Notes

1. Was an ‘a priori’ design provided?

Yes

There is no public protocol for

The research question and inclusion criteria should be

No

this review; it appears that

established before the conduct of the review.

Can’t answer
Not applicable

inclusion criteria were modified
during the review.

2. Was there duplicate study selection and data

Yes

Duplicate study selection is not

extraction?

No

mentioned. Duplicate data

There should be at least two independent data extractors and
a consensus procedure for disagreements should be in place.

Can’t answer

extraction was performed.

Not applicable

3. Was a comprehensive literature search performed?

Yes

Electronic searches are not

At least two electronic sources should be searched. The report

No

described in sufficient detail.

must include years and databases used (e.g. Central, EMBASE,
and MEDLINE). Key words and/or MESH terms must be
stated and where feasible the search strategy should be
provided. All searches should be supplemented by consulting
current contents, reviews, textbooks, specialized registers, or
experts in the particular field of study, and by reviewing the
references in the studies found.

Can’t answer
Not applicable

Little information is available
on search for relevant
unpublished studies.
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4. Was the status of publication (i.e. grey literature) used

Yes

Only published studies were

as an inclusion criterion?

No

included.

The authors should state that they searched for reports
regardless of their publication type. The authors should state
whether or not they excluded any reports (from the

Can’t answer
Not applicable

systematic review), based on their publication status,
language etc.
5. Was a list of studies (included and excluded) provided?

Yes

List of excluded studies is

A list of included and excluded studies should be provided.

No

missing.

Can’t answer
Not applicable
6. Were the characteristics of the included studies

Yes

Missing data on demographics

provided?

No

and some outcomes.

In an aggregated form such as a table, data from the original
studies should be provided on the participants, interventions
and outcomes. The ranges of characteristics in all the studies
analyzed e.g. age, race, sex, relevant socioeconomic data,
disease status, duration, severity, or other diseases should be
reported.

Can’t answer
Not applicable
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7. Was the scientific quality of the included studies

Yes

Authors adapted and used an

assessed and documented?

No

overall scale that does not

‘A priori’ methods of assessment should be provided (e.g., for
effectiveness studies if the author(s) chose to include only
randomized, double-blind, placebo controlled studies, or

Can’t answer
Not applicable

allocation concealment as inclusion criteria); for other types

assess risk of bias (selection,
performance, detection,
attrition bias, etc.). Quality
ratings were not provided.

of studies alternative items will be relevant.
8. Was the scientific quality of the included studies used

Yes

Insufficient assessment of

appropriately in formulating conclusions?

No

methodological quality.

The results of the methodological rigor and scientific quality
should be considered in the analysis and the conclusions of
the review, and explicitly stated in formulating

Can’t answer
Not applicable

recommendations.
9. Were the methods used to combine the findings of

Yes

Inappropriate statistical

studies appropriate?

No

methods.

For the pooled results, a test should be done to ensure the
studies were combinable, to assess their homogeneity (i.e.
Chi-squared test for homogeneity, I²). If heterogeneity exists a
random effects model should be used and/or the clinical
appropriateness of combining should be taken into
consideration (i.e. is it sensible to combine?).

Can’t answer
Not applicable
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10. Was the likelihood of publication bias assessed?

Yes

Outdated and inappropriate

An assessment of publication bias should include a

No

methods for assessment of

combination of graphical aids (e.g., funnel plot, other available
tests) and/or statistical tests (e.g., Egger regression test).

Can’t answer

publication bias.

Not applicable

11. Was the conflict of interest stated?

Yes

The authors did not provide a

Potential sources of support should be clearly acknowledged in

No

statement on conflict of

both the systematic review and the included studies.

Can’t answer
Not applicable

interest. JAMA noted that
authors made no financial
disclosures.

